Prothena

Yahoo Finance • 7 months ago

We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This Year

Key Insights Prothena to hold its Annual General Meeting on 14th of May Salary of US$630.5k is part of CEO Gene Kinney's total remuneration Total compensation is similar to the industry average Over the past three years, Prothena's EPS fe... Full story

Yahoo Finance • last year

Prothena Corp PLC (PRTA) Reports Q3 2023 Financial Results

Prothena Corp PLC (NASDAQ:PRTA) reported net income of $21.9 million for Q3 2023, compared to a net loss of $45.8 million for Q3 2022. The company received a $55 million payment from Bristol Myers Squibb for exclusive worldwide license to... Full story

Yahoo Finance • 2 years ago

Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023

Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid beta with high binding potency Demonstrated 20-fold higher affinity to amyloid beta... Full story

Yahoo Finance • 2 years ago

Prothena to Highlight Next Generation Treatments for Alzheimer’s and Parkinson’s Disease at the AD/PD 2023 Meeting

Broad participation at this year's congress highlights Prothena's leadership in advancing next generation treatments for Alzheimer’s and Parkinson’s disease Oral presentation on PRX012, Prothena’s next generation anti-amyloid beta antibody... Full story

Yahoo Finance • 2 years ago

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

DUBLIN, Ireland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today... Full story

Yahoo Finance • 2 years ago

Prothena (NASDAQ:PRTA) delivers shareholders strong 57% CAGR over 3 years, surging 6.6% in the last week alone

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But if you buy shares in a really great company, you can more than double your money. For instance the Prothena... Full story

Yahoo Finance • 2 years ago

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of novel investigational therapeutics built on protein dysregulation expertise,... Full story

Yahoo Finance • 2 years ago

Prothena to Report Second Quarter 2022 Financial Results on August 8th

DUBLIN, Ireland, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, annou... Full story

Yahoo Finance • 2 years ago

Prothena to Participate in Jefferies Healthcare Conference

DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today... Full story